![Mark H. Zizzamia](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ursprung des Netzwerks ersten Grades von Mark H. Zizzamia
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Griffin Securities, Inc.
![]() Griffin Securities, Inc. Investment Banks/BrokersFinance Headquartered in New York City, Griffin Securities, Inc. is a research-driven investment banking firm providing corporate finance, merger & acquisitions, brokerage and investment opportunities for institutional, corporate and private clients. Orders can be entered on major U.S. exchanges and most international exchanges. Positions can be held in multiple currencies. Griffin's research focuses on delivering objective, value-added research and winning ideas in several industries including healthcare/biotechnology, technology and telecommunications. They are a member of the NASD and the SIPC. Griffin Securities was founded in 1997.
6
| Private Company | Investment Banks/Brokers | 6 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Mark H. Zizzamia
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Bear Stearns Asset Management, Inc.
![]() Bear Stearns Asset Management, Inc. Investment ManagersFinance Bear Stearns Asset Management Inc (Bear Stearns) is a Private Equity/Venture Capital firm, a subsidiary of The Bear Stearns Cos LLC founded in 1985. The firm is headquartered in the US. | Investment Managers | Corporate Officer/Principal | |
Paradigm Capital Management, Inc.
![]() Paradigm Capital Management, Inc. Investment ManagersFinance Paradigm Capital Management, Inc. (Paradigm) is a SEC-registered investment advisor and wealth management firm headquartered in Albany, New York. The firm was founded by Candace Weir in 1994 and is a wholly owned subsidiary of Paradigm Capital Holdings, Inc. Paradigm offers investment advisory services primarily to corporations, pension and profit-sharing plans, foundations, individuals, investment funds, trusts and individuals (which include high net-worth individuals), other separate accounts, and pooled investment vehicles such as private investment limited partnerships. | Investment Managers | Portfolio Manager-Equities | |
Dialog Group, Inc.
![]() Dialog Group, Inc. Advertising/Marketing ServicesCommercial Services Dialog Group, Inc. provides advertising and marketing services. It engages in the provision of broad spectrum of proprietary and exclusive databases for healthcare, consumer and business-to-business market clients. The company was founded in 1982 and is headquartered in New York, NY. | Advertising/Marketing Services | Director/Board Member | |
Cantor Fitzgerald Securities
![]() Cantor Fitzgerald Securities Investment Banks/BrokersFinance Cantor Fitzgerald Securities (CFS) is a financial services provider headquartered in New York City and was founded in 1945. They are a subsidiary of Cantor Fitzgerald LP and their ultimate parent is CF Group Management, Inc. CFS offers an array of financial products and services in the equity and fixed-income capital markets. The firm provides sales and trading, investment banking, asset management, market commentary and market data. | Investment Banks/Brokers | Analyst-Equity | |
VACCINEX, INC. | Biotechnology | Director/Board Member | |
Agilis Biotherapeutics LLC
![]() Agilis Biotherapeutics LLC BiotechnologyHealth Technology Agilis Biotherapeutics LLC operates as a biotechnology company. It focuses on designing and engineering first-in-class DNA-based therapeutics to improve and save the lives of patients affected by life-threatening or fatal rare diseases for which there are no or limited treatment options. The company was founded in 2013 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
University of Pennsylvania | College/University | Undergraduate Degree | |
Boston University | College/University | Masters Business Admin | |
GSAM Strategist Portfolios LLC
![]() GSAM Strategist Portfolios LLC Investment ManagersFinance Standard & Poor's Investment Advisory Services LLC (SPIAS) is investment research firm and registered investment advisor headquartered in New York City. The firm is a wholly-owned subsidiary of S&P Global, Inc. (NYSE: SPGI), formerly McGraw Hill Financial, Inc. SPIAS’ advisory services are generally offered to institutions (e.g., broker-dealers, investment advisers, investment companies and other financial institutions). SPIAS does not generally provide its advisory services directly to retail clients, but its services may be used by its clients in advising their own underlying clients, which may include retail clients. SPIAS also provides advisory consulting services to institutional clients and investment managers-of-investment funds, and investment sub-advisory services for registered investment companies, including open-end mutual funds and other institutions. S&P Global's operations consist of three reportable segments: S&P Global Ratings, S&P Global Platts, and S&P Dow Jones Indices. S&P Global Ratings is an independent provider of credit ratings, research and analytics to investors, issuers and market participants. It includes the NRSRO and certain other ratings-related businesses. S&P Global Platts provides essential price data, analytics, and industry insight that enable commodities markets to perform with greater transparency and efficiency. S&P Dow Jones Indices is a global index provider that maintains a wide variety of indices to meet an array of investor needs. In 2016, CFRA acquired S&P Global Market Intelligence’s Equity and Fund Research business (formerly known as S&P Capital IQ and SNL) from S&P Global, Inc. | Investment Managers | Corporate Officer/Principal | |
Argus Research Co.
![]() Argus Research Co. Investment ManagersFinance Argus Research Co. (ARC) is a research firm headquartered in New York City and was founded in 1934. The firm is a subsidiary of Argus Research Group, Inc. ARC produces, distributes and markets investment and economic research. | Investment Managers | Corporate Officer/Principal | |
Lazard Asset Management LLC
![]() Lazard Asset Management LLC Investment ManagersFinance Lazard Asset Management LLC (LAM) is a SEC-registered investment advisor headquartered in New York City. The firm was founded in 1970 and is a wholly-owned subsidiary of Lazard Frères & Co. LLC, ultimately held by Lazard, Inc. (NYSE: LAZ). LAM manages investment portfolios and provides investment advice to institutional and individual investors around the world. | Investment Managers | Portfolio Manager-Equities | |
University of California, Los Angeles | College/University | Undergraduate Degree | |
Brooklyn College | College/University | Masters Business Admin | |
University of California, Berkeley | College/University | Masters Business Admin | |
Vassar College | College/University | Undergraduate Degree | |
National Securities & Research Corp. | Corporate Officer/Principal | ||
The Leonard N Stern School of Business | College/University | Masters Business Admin | |
Oncxerna Therapeutics, Inc.
![]() Oncxerna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oncxerna Therapeutics, Inc. develops oncology drugs. The firm uses RNA-based biomarker platform. It focuses on clinical-stage therapies. The company was founded by Laura E. Benjamin in 2018 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
PTC Therapeutics GT, Inc.
![]() PTC Therapeutics GT, Inc. Medical SpecialtiesHealth Technology Part of PTC Therapeutics, Inc., PTC Therapeutics GT, Inc. is a company that innovates DNA therapeutics to provide long-term efficacy for patients with debilitating and fatal diseases. The company is based in Lynnfield, MA. The company was founded by Chrystyna Bedrij Stecyk. | Medical Specialties | Founder | |
Aletheia Biotherapeutics LLC
![]() Aletheia Biotherapeutics LLC Medical/Nursing ServicesHealth Services Aletheia Biotherapeutics LLC operates as a clinical stage biotechnology company. It provides cancer-associated epithelial-to-mesenchyme transition with its AB-16B5 monoclonal antibody. The company is headquartered in New York, NY. | Medical/Nursing Services | Corporate Officer/Principal | |
ORION BIOTECH OPPORTUNITIES CORP. | Financial Conglomerates | Founder | |
Maavrx Ltd. | Director/Board Member | ||
Myrtelle LLC
![]() Myrtelle LLC Miscellaneous Commercial ServicesCommercial Services Myrtelle LLC is a gene therapy company that specializes in developing treatments for neurodegenerative diseases. Myrtelle is based in New York, NY. The company has a proprietary platform, intellectual property, and a portfolio of programs and technologies that support innovative gene therapy approaches. The company has an exclusive worldwide licensing agreement with Pfizer Inc. for its Canavan disease program. | Miscellaneous Commercial Services | Director/Board Member | |
Myrtelle, Inc. | Biotechnology | Chief Executive Officer |
Statistik
International
Vereinigte Staaten | 32 |
Vereinigtes Königreich | 3 |
Sektoral
Finance | 16 |
Consumer Services | 8 |
Health Technology | 6 |
Commercial Services | 3 |
Process Industries | 2 |
Operativ
Analyst-Equity | 10 |
Corporate Officer/Principal | 9 |
Director/Board Member | 6 |
Founder | 5 |
Undergraduate Degree | 4 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Mark H. Zizzamia
- Unternehmensverbindungen